Skip to main content
Caplight Logo









DNA Nanobots

DNA Nanobots

Private
Powell, OhioHealthcare & Life Scienceshttps://dnananobots.com/

Last Round

Seed

Dec 17, 2025

Total Funding Raised

$3.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DNA Nanobots is a biotechnology company that develops DNA nanotechnology-based solutions for biomedical applications, including targeted cancer drug delivery, vaccine development, and nucleic acid biosensing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

DNA origaminon-viral gene therapytargeted drug deliverynanomedicineDNA nanobotsgene delivery platformself-assembling nanostructuresCRISPR deliverytargeted chemotherapycancer vaccine deliverynucleic acid biosensingbiopharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DNA Nanobots Comparables

Compare DNA Nanobots with similar companies based on industry and business-model similarity.

DNA Nanobots comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DoriNano
89%
Code Biotherapeutics
85%
Eli Lilly and Company
78%

DNA Nanobots Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 17, 2025
Pre SeedJan 24, 2024

Key People

Founding team and executive leadership

Christopher Lucas

Co-Founder And Chief Science Officer

Founding Team

Patrick Halley

Co-Founder Chief Technology Officer

Founding Team

James F. Lynch

Chief Executive Officer

Executive Team

Jeff Spitzner

Founding CEO and Chief Strategist

Founding Team

DNA Nanobots Investors

Notable investors and investment history

DNA Nanobots investors
InvestorRounds
Ohio State Early Investor NetworkPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Grew 42% QoQ, from 12 to 17 employees.

  • Jul 24, 2026

    Monthly visitors increased 65% MoM.

DNA Nanobots Filings

Explore SEC and related filing metadata, where available.

DNA Nanobots filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DNA Nanobots's valuation, stock price, and market status.

Is DNA Nanobots a public or private company?

DNA Nanobots is a private company.

What is the current stock price of DNA Nanobots?

DNA Nanobots is a private company with no public stock price. No recent secondary market data is available.

How much is DNA Nanobots worth (valuation)?

Valuation information for DNA Nanobots is not publicly available.

Can I buy DNA Nanobots stock?

DNA Nanobots shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DNA Nanobots's last funding round?

DNA Nanobots's most recent funding round was Seed on December 17, 2025.

Who are the main investors in DNA Nanobots?

Key investors in DNA Nanobots include Ohio State Early Investor Network.

Will DNA Nanobots IPO soon?

No public IPO plans have been announced for DNA Nanobots.

How can I track DNA Nanobots secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DNA Nanobots's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPowell, Ohio
Employee Range13
Year Founded2021
Last FundingDec 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?